Switzerland· 65882001
Praluent 75 mg, solution injectable en stylo prérempli
A alirocumab product, registered in Switzerland by Sanofi-Aventis (Suisse) SA and dispensed under Swissmedic category B. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Alirocumab is registered in 15 of 19 countries.
Countries holding a registration under ATC C10AX14 (alirocumab), each read from that country’s own register.
- This record: Switzerland
- 10 of them publish a price we can compare per daily dose
Alirocumab · ATC C10AX14
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of alirocumab costs, country by country.
Normalised to the WHO defined daily dose (5.4 mg), so markets compare like for like.
- Switzerland: $16.93 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Alirocumab · price per daily dose (5.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$16.93
The record
At a glance
- Manufacturer
- Sanofi-Aventis (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- C10AX14
- ATC class
- Alirocumab
- Defined daily dose
- 5.4 mg, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10AX14
Alirocumab, as other registers publish it.
- United StatesPraluentSanofi-Aventis U.S. LLC
- United StatesPraluentRegeneron Pharmaceuticals, Inc.
- FinlandPraluentSanofi Winthrop Industrie
- FinlandPraluentSanofi Winthrop Industrie
- FinlandPraluentSanofi Winthrop Industrie
- DenmarkPraluentSanofi Winthrop Industrie
- FinlandPraluentSanofi Winthrop Industrie
- PolandPraluentSanofi Winthrop Industrie
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da9565cb-fcd2-4bc9-95e0-6f9faf2c55f5 GET /v1/drugs/da9565cb-fcd2-4bc9-95e0-6f9faf2c55f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about alirocumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.